IO biomarker
|
TP53 (Tumor protein P53) • BCL2 (B-cell CLL/lymphoma 2) • ATM (ATM serine/threonine kinase) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A) • DNMT3A (DNA methyltransferase 1) • CCND1 (Cyclin D1) • BCL6 (B-cell CLL/lymphoma 6) • SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 4) • CDKN2B (Cyclin Dependent Kinase Inhibitor 2B) • NOTCH2 (Notch 2) • CARD11 (Caspase Recruitment Domain Family Member 11) • MALT1 (MALT1 Paracaspase) • NFKBIE (NFKB Inhibitor Epsilon) • MIR15A (MicroRNA 15a)
|
TP53 mutation • ATM mutation • DNMT3A mutation • CDKN2A deletion • SMARCA4 mutation • CARD11 amplification • Chr del(13)(q14) • CCND1 mutation